The impact of diabetes mellitus on biomarkers for the diagnosis of periprosthetic joint infection
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1720431 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Tianmiao Cheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center of Clinical Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Biomarkers, Prosthesis-Related Infections, Diabetes Mellitus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objective
The aim of this study is to explore the impact of diabetes on the diagnosis of periprosthetic joint infection (PJI) by evaluating the levels of biomarkers and their diagnostic efficacy.
Methods
According to the diagnostic criteria for diabetes mellitus (DM), 394 patients were divided into the DM group (n=113) and the Non-DM group (n=281); each of these two groups was further subdivided into the PJI group and the aseptic loosening (AL) group based on the presence or absence of PJI. The levels of C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen (FIB), D-dimer, CRP-albumin ratio (CAR), and CRP-FIB ratio (CFR) were collected from all patients. Receiver operating characteristic (ROC) curves were used to evaluate the diagnostic efficacy of the aforementioned biomarkers under different glucose metabolism statuses.
Results
In both the DM group and the Non-DM group, the levels of all biomarkers in patients with PJI were significantly higher than those in patients with AL (P<0.001). The CAR showed the highest diagnostic efficacy in both groups (AUC = 0.918 in the DM group and AUC = 0.931 in the Non-DM group). Notably, compared with the Non-DM group, the optimal cut-off values of CRP and ESR were elevated in the DM group (CRP: 9.960 mg/L vs 7.895 mg/L; ESR: 43.0 mm/h vs 36.5 mm/h).
Conclusion
Diabetes does not affect the biomarker levels in patients with PJI. However, for diabetic patients, the diagnostic thresholds of CRP and ESR are relatively higher. Thus, caution should be exercised in clinical diagnosis to avoid false positives. Among all indicators, the CAR demonstrates the best diagnostic efficacy and can serve as the preferred biomarker for PJI patients with comorbid diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Clinical Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, China.
Zitieren
APA
Cheng, T., Chen, X., Ding, H., Qu, C., Chen, J., Zheng, D., & Qiu, J. (2025). The impact of diabetes mellitus on biomarkers for the diagnosis of periprosthetic joint infection. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1720431
Vancouver
Cheng T, Chen X, Ding H, Qu C, Chen J, Zheng D, et al. The impact of diabetes mellitus on biomarkers for the diagnosis of periprosthetic joint infection. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1720431
BibTeX
@article{Cheng2025,
author = {Cheng, Tianmiao and Chen, Xi and Ding, Hairong and Qu, Cifu and Chen, Jing and Zheng, Dong and Qiu, Jun},
title = {The impact of diabetes mellitus on biomarkers for the diagnosis of periprosthetic joint infection},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1720431}
}
EUVIMED